SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-054172
Filing Date
2020-11-16
Accepted
2020-11-16 16:06:55
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-10q_20200930.htm 10-Q 2617683
2 EX-31.1 annx-ex311_333.htm EX-31.1 18919
3 EX-31.2 annx-ex312_331.htm EX-31.2 18851
4 EX-32.1 annx-ex321_332.htm EX-32.1 14645
  Complete submission text file 0001564590-20-054172.txt   6408361

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT annx-20200930.xml EX-101.INS 995502
6 XBRL TAXONOMY EXTENSION SCHEMA annx-20200930.xsd EX-101.SCH 40354
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE annx-20200930_cal.xml EX-101.CAL 36333
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE annx-20200930_def.xml EX-101.DEF 144800
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE annx-20200930_lab.xml EX-101.LAB 341663
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE annx-20200930_pre.xml EX-101.PRE 262397
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 201316800
SIC: 2834 Pharmaceutical Preparations